These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38419941)
41. Targeting murine alveolar macrophages by the intratracheal administration of locked nucleic acid containing antisense oligonucleotides. Uemura Y; Kobayashi K Drug Deliv; 2019 Dec; 26(1):803-811. PubMed ID: 31385541 [TBL] [Abstract][Full Text] [Related]
42. Chronic Toxicity Assessment of 2'-O-Methoxyethyl Antisense Oligonucleotides in Mice. Zanardi TA; Kim TW; Shen L; Serota D; Papagiannis C; Park SY; Kim Y; Henry SP Nucleic Acid Ther; 2018 Aug; 28(4):233-241. PubMed ID: 29708844 [TBL] [Abstract][Full Text] [Related]
43. Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice. Yu RZ; Graham MJ; Post N; Riney S; Zanardi T; Hall S; Burkey J; Shemesh CS; Prakash TP; Seth PP; Swayze EE; Geary RS; Wang Y; Henry S Mol Ther Nucleic Acids; 2016 May; 5(5):e317. PubMed ID: 27138177 [TBL] [Abstract][Full Text] [Related]
44. Comparing in vitro and in vivo activity of 2'-O-[2-(methylamino)-2-oxoethyl]- and 2'-O-methoxyethyl-modified antisense oligonucleotides. Prakash TP; Kawasaki AM; Wancewicz EV; Shen L; Monia BP; Ross BS; Bhat B; Manoharan M J Med Chem; 2008 May; 51(9):2766-76. PubMed ID: 18399648 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides. Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051 [TBL] [Abstract][Full Text] [Related]
46. Antisense oligonucleotides and nucleic acids generate hypersensitive platelets. Zaslavsky A; Adams M; Cao X; Yamaguchi A; Henderson J; Busch-Østergren P; Udager A; Pitchiaya S; Tourdot B; Kasputis T; Church SJ; Lee SK; Ohl S; Patel S; Morgan TM; Alva A; Wakefield TW; Reichert Z; Holinstat M; Palapattu GS Thromb Res; 2021 Apr; 200():64-71. PubMed ID: 33540294 [TBL] [Abstract][Full Text] [Related]
47. Antisense oligonucleotides for the treatment of dyslipidaemia. Visser ME; Witztum JL; Stroes ES; Kastelein JJ Eur Heart J; 2012 Jun; 33(12):1451-8. PubMed ID: 22634577 [TBL] [Abstract][Full Text] [Related]
48. Differential Uptake of Antisense Oligonucleotides in Mouse Hepatocytes and Macrophages Revealed by Simultaneous Two-Photon Excited Fluorescence and Coherent Raman Imaging. Mukherjee P; Aksamitiene E; Alex A; Shi J; Bera K; Zhang C; Spillman DR; Marjanovic M; Fazio M; Seth PP; Frazier K; Hood SR; Boppart SA Nucleic Acid Ther; 2022 Jun; 32(3):163-176. PubMed ID: 34797690 [TBL] [Abstract][Full Text] [Related]
49. Drug Discovery Perspectives of Antisense Oligonucleotides. Kim Y Biomol Ther (Seoul); 2023 May; 31(3):241-252. PubMed ID: 36859811 [TBL] [Abstract][Full Text] [Related]
50. Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates. Weidolf L; Björkbom A; Dahlén A; Elebring M; Gennemark P; Hölttä M; Janzén D; Li X; Andersson S Drug Discov Today; 2021 Oct; 26(10):2244-2258. PubMed ID: 33862193 [TBL] [Abstract][Full Text] [Related]
51. Hydrophobicity Tuning of Cationic Polyaspartamide Derivatives for Enhanced Antisense Oligonucleotide Delivery. Yum J; Aulia F; Kamiya K; Hori M; Qiao N; Kim BS; Naito M; Ogura S; Nagata T; Yokota T; Uchida S; Obika S; Kim HJ; Miyata K Bioconjug Chem; 2024 Feb; 35(2):125-131. PubMed ID: 38290165 [TBL] [Abstract][Full Text] [Related]
52. A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides. Dieckmann A; Hagedorn PH; Burki Y; Brügmann C; Berrera M; Ebeling M; Singer T; Schuler F Mol Ther Nucleic Acids; 2018 Mar; 10():45-54. PubMed ID: 29499955 [TBL] [Abstract][Full Text] [Related]
54. Metabolism and Disposition of Volanesorsen, a 2'- Post N; Yu R; Greenlee S; Gaus H; Hurh E; Matson J; Wang Y Drug Metab Dispos; 2019 Oct; 47(10):1164-1173. PubMed ID: 31350288 [TBL] [Abstract][Full Text] [Related]